TP53 and HIV infectious disease: Conversely, pre-treatment of cells with pifithrin, a known p53 antagonist, before HIV infection resulted in a significant reduction in the fraction of cells showing a quiescent phenotype (Cyclin D3−, Ki67−) compared to vehicle-treated cells (Fig. 4c and Extended Data Fig. 6i,j).